CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Pimavanserin

匹莫范色林 杂质对照品Pimavanserin Impurities

44 个杂质条目44 impurity entries

本页汇总 匹莫范色林 的 44 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 44 impurity reference standards of Pimavanserin. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 匹莫范色林(Pimavanserin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment of an analytical method for the determination of pimavanserin and its impurities applying analytical quality by design principles as a risk-based strategy
    Journal of pharmaceutical and biomedical analysis · 2021 · Radić I et al.  ·  PMID 33964725  ·  DOI
  2. 分析方法Analytical MethodsA Fully Validated UHPLC-MS/MS Method for the Estimation of Pimavanserin in Human (K2EDTA) Plasma and its Application to a Clinical Pharmacokinetic Study
    Journal of chromatographic science · 2022 · Aalapati KK et al.  ·  PMID 34109394  ·  DOI
  3. 分析方法Analytical MethodsDevelopment of a UPLC-MS/MS method for determination of pimavanserin tartrate in rat plasma: Application to a pharmacokinetic study
    Journal of pharmaceutical analysis · 2017 · Wang S et al.  ·  PMID 29404067  ·  DOI

匹莫范色林 —— 原料药与杂质对照品Pimavanserin — drug substance & impurities

共 45 个条目(含原料药本体)45 items incl. the drug substance
Pimavanserin structure
原料药 APIAPI
匹莫范色林Pimavanserin
Pimavanserin
CAS No.706779-91-1
Chemical FormulaC25H34FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin L-Tartrate structure
—
匹莫范色林 L-酒石酸盐Pimavanserin L-Tartrate
Pimavanserin L-Tartrate
CAS No.1080491-31-1
Chemical FormulaC25H34FN3O2·C4H6O6
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin L-Hemitartrate structure
—
匹莫范色林 L-半酒石酸盐Pimavanserin L-Hemitartrate
Pimavanserin L-Hemitartrate
CAS No.706782-28-7
Chemical FormulaC25H34FN3O2·1/2(C4H6O6)
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 1 Monomer structure
1
匹莫范色林杂质1单体Pimavanserin Impurity 1 Monomer
Pimavanserin Impurity 1 Monomer
CAS No.134227-41-1
Chemical FormulaC14H13F2N
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 1 structure
1
匹莫范色林杂质1Pimavanserin Impurity 1
Pimavanserin Impurity 1
CAS No.646051-52-7
Chemical FormulaC14H13F2N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 2  Monomer structure
2
匹莫范色林杂质2 单体Pimavanserin Impurity 2 Monomer
Pimavanserin Impurity 2 Monomer
CAS No.2322278-87-3
Chemical FormulaC22H31NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 2 structure
2
匹莫范色林杂质2Pimavanserin Impurity 2
Pimavanserin Impurity 2
CAS No.2514955-85-0
Chemical FormulaC22H31NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 3 structure
3
匹莫范色林杂质3Pimavanserin Impurity 3
Pimavanserin Impurity 3
CAS No.955997-87-2
Chemical FormulaC23H32N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 5 structure
5
匹莫范色林杂质5Pimavanserin Impurity 5
Pimavanserin Impurity 5
CAS No.1388858-78-3
Chemical FormulaC19H23FN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 7 structure
7
匹莫范色林杂质7Pimavanserin Impurity 7
Pimavanserin Impurity 7
CAS No.86010-68-6
Chemical FormulaC9H10FNO
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 8 Dihydrochloride structure
8
匹莫范色林杂质8 双盐酸盐Pimavanserin Impurity 8 Dihydrochloride
Pimavanserin Impurity 8 Dihydrochloride
CAS No.1837794-51-0
Chemical FormulaC13H19FN2·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 8 Hydrochloride structure
8
匹莫范色林杂质8 盐酸盐Pimavanserin Impurity 8 Hydrochloride
Pimavanserin Impurity 8 Hydrochloride
CAS No.2236586-71-1
Chemical FormulaC13H19FN2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 8 structure
8
匹莫范色林杂质8Pimavanserin Impurity 8
Pimavanserin Impurity 8
CAS No.359878-47-0
Chemical FormulaC13H19FN2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 9 structure
9
匹莫范色林杂质9Pimavanserin Impurity 9
Pimavanserin Impurity 9
CAS No.1134815-71-6
Chemical FormulaC25H34FN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 10 structure
10
匹莫范色林杂质10Pimavanserin Impurity 10
Pimavanserin Impurity 10
CAS No.107456-06-4
Chemical FormulaC14H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 11 structure
11
匹莫范色林杂质11Pimavanserin Impurity 11
Pimavanserin Impurity 11
CAS No.932724-63-5
Chemical FormulaC21H18F3N
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 12 structure
12
匹莫范色林杂质12Pimavanserin Impurity 12
Pimavanserin Impurity 12
CAS No.639863-75-5
Chemical FormulaC12H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 15 structure
15
匹莫范色林杂质15Pimavanserin Impurity 15
Pimavanserin Impurity 15
CAS No.2512201-55-5
Chemical FormulaC25H35N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 16 structure
16
匹莫范色林杂质16Pimavanserin Impurity 16
Pimavanserin Impurity 16
CAS No.2212-44-4
Chemical FormulaC21H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 18 structure
18
匹莫范色林杂质18Pimavanserin Impurity 18
Pimavanserin Impurity 18
CAS No.1246458-13-8
Chemical FormulaC25H32FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 22 structure
22
匹莫范色林杂质22Pimavanserin Impurity 22
Pimavanserin Impurity 22
CAS No.639863-77-7
Chemical FormulaC24H32FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 23 structure
23
匹莫范色林杂质23Pimavanserin Impurity 23
Pimavanserin Impurity 23
CAS No.84697-13-2
Chemical FormulaC11H17NO
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 25 structure
25
匹莫范色林杂质25Pimavanserin Impurity 25
Pimavanserin Impurity 25
CAS No.930045-10-6
Chemical FormulaC15H14F2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 26 structure
26
匹莫范色林杂质26Pimavanserin Impurity 26
Pimavanserin Impurity 26
CAS No.3778-85-6
Chemical FormulaC8H9ClN2S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 27 structure
27
匹莫范色林杂质27Pimavanserin Impurity 27
Pimavanserin Impurity 27
CAS No.57206-73-2
Chemical FormulaC15H14Cl2N2S
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 28 structure
28
匹莫范色林杂质28Pimavanserin Impurity 28
Pimavanserin Impurity 28
CAS No.133067-71-7
Chemical FormulaC8H9ClN2S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 29 Monomer structure
29
匹莫范色林杂质29 单体Pimavanserin Impurity 29 Monomer
Pimavanserin Impurity 29 Monomer
CAS No.4734-09-2
Chemical FormulaC11H17NO
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 29 structure
29
匹莫范色林杂质29Pimavanserin Impurity 29
Pimavanserin Impurity 29
CAS No.955997-89-4
Chemical FormulaC11H17NO·C2H4O2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 30 structure
30
匹莫范色林杂质30Pimavanserin Impurity 30
Pimavanserin Impurity 30
CAS No.635283-50-0
Chemical FormulaC9H10FNO
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 32 structure
32
匹莫范色林杂质32Pimavanserin Impurity 32
Pimavanserin Impurity 32
CAS No.428819-12-9
Chemical FormulaC14H11F2N
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 33 structure
33
匹莫范色林杂质33Pimavanserin Impurity 33
Pimavanserin Impurity 33
CAS No.31264-06-9
Chemical FormulaC14H11Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 34 structure
34
匹莫范色林杂质34Pimavanserin Impurity 34
Pimavanserin Impurity 34
CAS No.54560-80-4
Chemical FormulaC14H11Br2N
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 35 structure
35
匹莫范色林杂质35Pimavanserin Impurity 35
Pimavanserin Impurity 35
CAS No.71022-60-1
Chemical FormulaC16H17N
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 36 structure
36
匹莫范色林杂质36Pimavanserin Impurity 36
Pimavanserin Impurity 36
CAS No.1173710-95-6
Chemical FormulaC16H11N3
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 37 structure
37
匹莫范色林杂质37Pimavanserin Impurity 37
Pimavanserin Impurity 37
CAS No.459-56-3
Chemical FormulaC7H7FO
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 38 structure
38
匹莫范色林杂质38Pimavanserin Impurity 38
Pimavanserin Impurity 38
CAS No.13221-89-1
Chemical FormulaC8H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 43 structure
43
匹莫范色林杂质43Pimavanserin Impurity 43
Pimavanserin Impurity 43
CAS No.2565657-87-4
Chemical FormulaC46H69N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 47 structure
47
匹莫范色林杂质47Pimavanserin Impurity 47
Pimavanserin Impurity 47
CAS No.40141-14-8
Chemical FormulaC11H15ClO
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 49 structure
49
匹莫范色林杂质49Pimavanserin Impurity 49
Pimavanserin Impurity 49
CAS No.21244-29-1
Chemical FormulaC19H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 53 structure
53
匹莫范色林杂质53Pimavanserin Impurity 53
Pimavanserin Impurity 53
CAS No.3261-60-7
Chemical FormulaC16H17NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 55 structure
55
匹莫范色林杂质55Pimavanserin Impurity 55
Pimavanserin Impurity 55
CAS No.89-99-6
Chemical FormulaC7H8FN
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 62 structure
62
匹莫范色林杂质62Pimavanserin Impurity 62
Pimavanserin Impurity 62
CAS No.72235-52-0
Chemical FormulaC7H7F2N
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 63 structure
63
匹莫范色林杂质63Pimavanserin Impurity 63
Pimavanserin Impurity 63
CAS No.2913244-21-8
Chemical FormulaC17H20ClNO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 64 structure
64
匹莫范色林杂质64Pimavanserin Impurity 64
Pimavanserin Impurity 64
CAS No.69385-30-4
Chemical FormulaC7H7F2N
Purity>95%询价On request
10mg25mg50mg100mg
Pimavanserin Impurity 65 structure
65
匹莫范色林杂质65Pimavanserin Impurity 65
Pimavanserin Impurity 65
CAS No.459-60-9
Chemical FormulaC7H7FO
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

匹莫范色林 —— 研究文献与合成路线Pimavanserin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 匹莫范色林 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Pimavanserin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development of an analytical method for the determination of pimavanserin and its impurities applying analytical quality by design principles as a risk-based strategy
    Radić I, Runje M, Babić S · Journal of pharmaceutical and biomedical analysis · 2021 · 被引 6cited 6

合成路线文献Synthetic-route papers

  1. Design, Synthesis, Molecular Docking, and Biological Evaluation of Novel Pimavanserin-Based Analogues as Potential Serotonin 5-HT2A Receptor Inverse Agonists
    Albujuq NR, Meana JJ, Diez-Alarcia R, et al. · Journal of medicinal chemistry · 2023

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

匹莫范色林 杂质谱研究要点Pimavanserin — impurity profiling notes

下面这些是拿到 匹莫范色林 的 45 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 45 impurity entries for Pimavanserin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances